NCT00790660View on ClinicalTrials.gov

A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 23, 2008

Primary Completion Date

March 6, 2009

Study Completion Date

March 6, 2009

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

ASP1941

Oral

DRUG

Placebo

Oral

Trial Locations (1)

78229

San Antonio

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY